# Nexgel, Inc.: filings

NXGL · Nasdaq · CIK 1468929 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nxgl.md) · [Financials](/companies/nxgl/financials.md) · [Filings](/companies/nxgl/filings.md) · [Insiders](/companies/nxgl/insiders.md)

## Reports and events: 146 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 95, 8-K 94, 10-Q 22, 3 15, 144 10, CORRESP 10, 10-K 7, DEF 14A 7, D 6, S-1/A 6, 424B5 5, UPLOAD 5, 10-K/A 4, EFFECT 4, NT 10-Q 4, PRE 14A 4, S-1 4, DEF 14C 2, PRE 14C 2, S-3/A 2, SC 13D 2, 10-12G 1, 424B3 1, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, DEFA14A 1, DEFR14A 1, DRS 1, DRSLTR 1, NT 10-K 1, RW 1, S-1MEF 1, S-3 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-07 | 20:39 ET | [8-K](/filings/0001493152-26-046154.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-046154 |
| 2026-09-24 | 20:15 ET | [8-K](/filings/0001493152-26-044149.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-044149 |
| 2026-09-23 | 21:20 ET | [8-K](/filings/0001493152-26-043955.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-043955 |
| 2026-08-24 | 21:14 ET | [DEF 14A](/filings/0001493152-26-039890.md) | Proxy statement, period 2026-08-24 | 0001493152-26-039890 |
| 2026-08-21 | 20:42 ET | [8-K](/filings/0001493152-26-039708.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-039708 |
| 2026-08-20 | 16:39 ET | [S-1](/filings/0001493152-26-039421.md) | Registration statement | 0001493152-26-039421 |
| 2026-08-17 | 12:15 ET | [8-K](/filings/0001493152-26-038637.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-038637 |
| 2026-08-17 | 23:40 ET | [10-Q](/filings/0001493152-26-038555.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038555 |
| 2026-08-05 | 21:00 ET | [8-K](/filings/0001493152-26-036206.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-036206 |
| 2026-07-29 | 21:25 ET | [8-K](/filings/0001493152-26-035258.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-035258 |
| 2026-07-09 | 20:15 ET | [8-K](/filings/0001493152-26-032687.md) | 8.01 Other events | 0001493152-26-032687 |
| 2026-07-02 | 21:15 ET | [8-K](/filings/0001493152-26-031962.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-031962 |
| 2026-06-17 | 20:45 ET | [8-K](/filings/0001493152-26-029100.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-029100 |
| 2026-06-09 | 21:00 ET | [DEF 14A](/filings/0001493152-26-027965.md) | Proxy statement, period 2026-06-09 | 0001493152-26-027965 |
| 2026-05-15 | 20:31 ET | [8-K](/filings/0001493152-26-023851.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-023851 |
| 2026-05-14 | 21:29 ET | [10-Q](/filings/0001493152-26-023207.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023207 |
| 2026-05-12 | 20:30 ET | [8-K](/filings/0001493152-26-022503.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-022503 |
| 2026-04-30 | 20:54 ET | [10-K/A](/filings/0001493152-26-020692.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-020692 |
| 2026-04-30 | 20:49 ET | [8-K](/filings/0001493152-26-020657.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-020657 |
| 2026-04-24 | 21:15 ET | [8-K](/filings/0001493152-26-018962.md) | 3.01 Delisting notice | 0001493152-26-018962 |
| 2026-04-21 | 20:05 ET | [8-K](/filings/0001493152-26-018302.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018302 |
| 2026-03-31 | 21:31 ET | [10-K](/filings/0001493152-26-014377.md) | Annual report, period 2025-12-31 | 0001493152-26-014377 |
| 2026-03-10 | 13:17 ET | [8-K](/filings/0001493152-26-009474.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-009474 |
| 2026-02-11 | 13:33 ET | [8-K](/filings/0001493152-26-006124.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-006124 |
| 2026-01-30 | 22:00 ET | [8-K](/filings/0001493152-26-004535.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-004535 |
| 2026-01-07 | 21:15 ET | [8-K](/filings/0001493152-26-000813.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-000813 |
| 2025-12-11 | 21:15 ET | [8-K](/filings/0001493152-25-027245.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-027245 |
| 2025-11-24 | 21:15 ET | [8-K](/filings/0001493152-25-024829.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-024829 |
| 2025-11-12 | 13:06 ET | [8-K](/filings/0001493152-25-021742.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-021742 |
| 2025-11-12 | 13:01 ET | [10-Q](/filings/0001493152-25-021738.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021738 |
| 2025-10-30 | 20:15 ET | [DEF 14A](/filings/0001493152-25-020224.md) | Proxy statement, period 2025-10-30 | 0001493152-25-020224 |
| 2025-08-12 | 21:01 ET | [10-Q](/filings/0001641172-25-023236.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023236 |
| 2025-08-12 | 20:10 ET | [8-K](/filings/0001641172-25-023188.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023188 |
| 2025-08-05 | 20:05 ET | [8-K](/filings/0001641172-25-022240.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-022240 |
| 2025-08-01 | 20:05 ET | [8-K](/filings/0001641172-25-021893.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021893 |
| 2025-07-31 | 20:21 ET | [8-K](/filings/0001641172-25-021743.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-021743 |
| 2025-07-14 | 20:15 ET | [8-K](/filings/0001641172-25-019508.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-019508 |
| 2025-06-20 | 20:30 ET | [8-K](/filings/0001641172-25-015860.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-015860 |
| 2025-06-04 | 20:30 ET | [8-K](/filings/0001641172-25-013634.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-013634 |
| 2025-05-13 | 21:00 ET | [10-Q](/filings/0001641172-25-009988.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009988 |
| 2025-05-13 | 20:18 ET | [8-K](/filings/0001641172-25-009954.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009954 |
| 2025-04-30 | 21:01 ET | [DEF 14A](/filings/0001641172-25-007863.md) | Proxy statement, period 2025-04-30 | 0001641172-25-007863 |
| 2025-03-27 | 20:18 ET | [10-K](/filings/0001641172-25-000937.md) | Annual report, period 2024-12-31 | 0001641172-25-000937 |
| 2025-03-25 | 13:17 ET | [8-K](/filings/0001641172-25-000533.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-000533 |
| 2025-03-24 | 20:45 ET | [8-K](/filings/0001641172-25-000311.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-000311 |
| 2025-01-22 | 14:00 ET | [8-K](/filings/0001493152-25-003153.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-003153 |
| 2025-01-06 | 21:30 ET | [8-K](/filings/0001493152-25-001000.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-001000 |
| 2024-11-14 | 00:35 ET | [8-K](/filings/0001493152-24-045238.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045238 |
| 2024-11-13 | 22:29 ET | [10-Q](/filings/0001493152-24-045213.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045213 |
| 2024-11-12 | 14:04 ET | [8-K](/filings/0001493152-24-044582.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-044582 |

Page 1 of 3. [Older](/companies/nxgl/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.